Ignite Creation Date:
2024-05-05 @ 10:37 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01140412
Status:
TERMINATED
Last Update Posted:
2011-02-04
First Post:
2010-06-07
Brief Title:
Pharmacokinetic Interaction Between Maraviroc And FosamprenavirRitonavir In Healthy Subjects
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Study Overview
Official Title:
Open-Label Fixed-Sequence Crossover Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And FosamprenavirRitonavir In Healthy Subjects
Status:
TERMINATED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The trial prematurely terminated on November 1 2010 due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is will be an open-label fixed-sequence multiple dose crossover study in 2 cohorts of 14 healthy male andor female subjects to estimate the effect of maraviroc on the pharmacokinetics of amprenavir and ritonavir and fosamprenavirritonavir on the pharmacokinetics of maraviroc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None